학술논문
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
Document Type
Article
Author
Source
In The Lancet Infectious Diseases March 2017 17(3):313-321
Subject
Language
ISSN
1473-3099